May's edition of the IISS features Joanna Gould - CEO, VisusNano.
Talk title: Improving drug delivery in ophthalmology
VisusNano Ltd. is a pre-clinical company developing a pipeline of exciting drug-eluting intraocular lens implant for use in patients undergoing cataract surgery. By improving patient outcomes, obviating the need for eye drops after surgery, and avoiding the need for laser treatment after surgery, our project has the potential to revolutionise cataract surgery in both the human and veterinary markets.
To register for this event, click here.